The aim of the research group is to improve care in all points of the stroke treatment chains. All projects should have direct implications for clinical practice.
Appleton JP, Woodhouse LJ, Anderson CS, Ankolekar S, Cala L, Dixon M, England TJ, Krishnan K, Mair G, Muir KW, Potter J, Price CI, Randall M, Robinson TG, Roffe C, Sandset EC, Saver JL, Shone A, Siriwardena AN, Wardlaw JM, Sprigg N, Bath PM, RIGHT-2 Investigators(2024) Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial Stroke Vasc Neurol, 9(1), 38-49 DOI 10.1136/svn-2022-001634, PubMed 37290930
Guterud M, Hardeland C, Bugge HF, Sandset EC, Svendsen EJ, Hov MR(2024) Experiences from a cluster-randomized trial (ParaNASPP) exploring triage and diagnostic accuracy in paramedic-suspected stroke: a qualitative interview study Eur J Neurol, 31(5), e16252 DOI 10.1111/ene.16252, PubMed 38404142
Heffernan M, Woodward M, De Silva DA, Chen C, Anderson CS, Kremer C, Harris K, Sandset EC, Ferretti MT, Caso V, Carcel C(2024) Sex and gender publications in brain health: a mapping review of the Asia-Pacific region Cerebrovasc Dis(in press) DOI 10.1159/000537946, PubMed 38402856
